abstract |
The present invention relates to compounds that are inhibitors of the enzyme dipeptidyl peptidase-IV ("DP-IV inhibitors") and are used to treat or prevent diseases involving the enzyme dipeptidyl peptidase IV, such as diabetes and, in particular, type 2 diabetes. The invention also refers to pharmaceutical compositions containing such compounds, and the use of such compounds and compositions for the prevention or treatment of such diseases in which the enzyme dipeptidyl peptidase-IV is involved. |